Cargando…

Searching for Multi-Targeting Neurotherapeutics against Alzheimer’s: Discovery of Potent AChE-MAO B Inhibitors through the Decoration of the 2H-Chromen-2-one Structural Motif

The need for developing real disease-modifying drugs against neurodegenerative syndromes, particularly Alzheimer’s disease (AD), shifted research towards reliable drug discovery strategies to unveil clinical candidates with higher therapeutic efficacy than single-targeting drugs. By following the mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pisani, Leonardo, Farina, Roberta, Soto-Otero, Ramon, Denora, Nunzio, Mangiatordi, Giuseppe Felice, Nicolotti, Orazio, Mendez-Alvarez, Estefania, Altomare, Cosimo Damiano, Catto, Marco, Carotti, Angelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273473/ https://www.ncbi.nlm.nih.gov/pubmed/26999091 http://dx.doi.org/10.3390/molecules21030362

Ejemplares similares

Chasing ChEs-MAO B Multi-Targeting 4-Aminomethyl-7-Benzyloxy-2H-Chromen-2-ones
por: Rullo, Mariagrazia, et al.
Publicado: (2019)

Investigation on Novel E/Z 2-Benzylideneindan-1-One-Based Photoswitches with AChE and MAO-B Dual Inhibitory Activity
por: Paolino, Marco, et al.
Publicado: (2023)

First Synthesis of Racemic Trans Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer’s Disease
por: Guieu, Benjamin, et al.
Publicado: (2020)

Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders
por: Mathew, Bijo, et al.
Publicado: (2021)

First-in-Class Isonipecotamide-Based Thrombin and Cholinesterase Dual Inhibitors with Potential for Alzheimer Disease
por: Purgatorio, Rosa, et al.
Publicado: (2021)

A twenty-year journey exploring coumarin-based derivatives as bioactive molecules
por: Pisani, Leonardo, et al.
Publicado: (2022)

Pharmacophore Modeling and 3D-QSAR Study of Indole and Isatin Derivatives as Antiamyloidogenic Agents Targeting Alzheimer’s Disease †
por: Purgatorio, Rosa, et al.
Publicado: (2020)

Human Aquaporin-4 and Molecular Modeling: Historical Perspective and View to the Future
por: Mangiatordi, Giuseppe Felice, et al.
Publicado: (2016)

Synthesis of Novel Benzo[b][1,6]naphthyridine Derivatives and Investigation of Their Potential as Scaffolds of MAO Inhibitors
por: Kulikova, Larisa N., et al.
Publicado: (2023)

Assessing the Role of a Malonamide Linker in the Design of Potent Dual Inhibitors of Factor Xa and Cholinesterases
por: Purgatorio, Rosa, et al.
Publicado: (2022)

A generalizable definition of chemical similarity for read-across
por: Floris, Matteo, et al.
Publicado: (2014)

Insights into the Complex Formed by Matrix Metalloproteinase-2 and Alloxan Inhibitors: Molecular Dynamics Simulations and Free Energy Calculations
por: Giangreco, Ilenia, et al.
Publicado: (2011)

Role of multidrug transporters in neurotherapeutics
por: Jose, Manna, et al.
Publicado: (2009)

Neurotherapeutics for ADHD: Do they work?
por: Rubia, Katya
Publicado: (2022)

In Vivo Investigation of (2-Hydroxypropyl)-β-cyclodextrin-Based Formulation of Spironolactone in Aqueous Solution for Paediatric Use
por: Lopalco, Antonio, et al.
Publicado: (2022)

Identification of New N-methyl-piperazine Chalcones as Dual MAO-B/AChE Inhibitors
por: El-Damasy, Ashraf K., et al.
Publicado: (2023)

Bcr-Abl Tyrosine Kinase Inhibitors in the Treatment of Pediatric CML
por: Carofiglio, Francesca, et al.
Publicado: (2020)

Accelerating Drug Discovery by Early Protein Drug Target Prediction Based on a Multi-Fingerprint Similarity Search †
por: Montaruli, Michele, et al.
Publicado: (2019)

Editorial: Glaucoma: In Search of Better Neurotherapeutics
por: Russo, Rossella, et al.
Publicado: (2018)

Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2021)

Updates and advances in multiple sclerosis neurotherapeutics
por: Amin, Moein, et al.
Publicado: (2022)

Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B Inhibitors
por: Alagöz, Mehmet Abdullah, et al.
Publicado: (2022)

Neuroprotective, neurotherapeutic, and neurometabolic effects of carbon monoxide
por: Mahan, Vicki L
Publicado: (2012)

The social neuroscience of psychosis: From neurobiology to neurotherapeutics
por: Mehta, Urvakhsh Meherwan
Publicado: (2020)

Mitochondrial Photobiomodulation as a Neurotherapeutic Strategy for Epilepsy
por: Cardoso, Fabrízio dos Santos, et al.
Publicado: (2022)

Chemical and Biological Evaluation of Novel 1H-Chromeno[3,2-c]pyridine Derivatives as MAO Inhibitors Endowed with Potential Anticancer Activity
por: Kulikova, Larisa N., et al.
Publicado: (2023)

Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders
por: Koyiparambath, Vishal Payyalot, et al.
Publicado: (2021)

Making sense of chemical space network shows signs of criticality
por: Amoroso, Nicola, et al.
Publicado: (2023)

A Prospective Repurposing of Dantrolene as a Multitarget Agent for Alzheimer’s Disease
por: Bolognino, Isabella, et al.
Publicado: (2019)

Design, Synthesis, and Biological Evaluation of Pyridazinones Containing the (2-Fluorophenyl) Piperazine Moiety as Selective MAO-B Inhibitors
por: Çeçen, Muhammed, et al.
Publicado: (2020)

Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics
por: Olson, David E
Publicado: (2018)

Molecular Mechanisms of Astaxanthin as a Potential Neurotherapeutic Agent
por: Bahbah, Eshak I., et al.
Publicado: (2021)

Biomaterials for Neurotherapeutics: From Lab Discovery to Clinical Application
por: Ao, Qiang
Publicado: (2021)

Mechanisms of manganese-induced neurotoxicity and the pursuit of neurotherapeutic strategies
por: Pajarillo, Edward, et al.
Publicado: (2022)

Neurosteroids as stress modulators and neurotherapeutics: lessons from the retina
por: Izumi, Yukitoshi, et al.
Publicado: (2022)

Neurotherapeutic potential of intranasal administration of human breast milk
por: Malhotra, Atul
Publicado: (2023)

Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2023)

Homobivalent Lamellarin-Like Schiff Bases: In Vitro Evaluation of Their Cancer Cell Cytotoxicity and Multitargeting Anti-Alzheimer’s Disease Potential
por: Nevskaya, Alisa A., et al.
Publicado: (2021)

Maó
por: Quintana, Josep M. (Josep Maria)
Publicado: (1996)

Insights into Structure-Activity Relationships of 3-Arylhydrazonoindolin-2-One Derivatives for Their Multitarget Activity on β-Amyloid Aggregation and Neurotoxicity
por: Purgatorio, Rosa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e32g188vnp3c8603qn20e4mhqg